November 29, 2017 / 10:45 AM / 19 days ago

BRIEF-Jiangsu Hengrui Medicine passes U.S. FDA approval

Nov 29(Reuters) - Jiangsu Hengrui Medicine Co Ltd

* Says it received FDA approval for Dexmedetomidine Hydrochloride Injection from U.S. Food and Drug Administration

* Company will be able to sell its Dexmedetomidine Hydrochloride Injection in the United States after receiving the FDA approval

Source text in Chinese: goo.gl/QvftFS

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below